Free Trial

XTX Topco Ltd Sells 73,220 Shares of agilon health, inc. (NYSE:AGL)

agilon health logo with Medical background

XTX Topco Ltd trimmed its stake in agilon health, inc. (NYSE:AGL - Free Report) by 61.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 46,527 shares of the company's stock after selling 73,220 shares during the quarter. XTX Topco Ltd's holdings in agilon health were worth $88,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the stock. Oak Thistle LLC bought a new stake in shares of agilon health in the fourth quarter valued at about $25,000. Ieq Capital LLC acquired a new position in shares of agilon health during the 4th quarter worth approximately $26,000. Signaturefd LLC increased its holdings in shares of agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock worth $27,000 after purchasing an additional 8,467 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of agilon health in the fourth quarter valued at approximately $33,000. Finally, Cerity Partners LLC bought a new stake in shares of agilon health in the fourth quarter valued at approximately $34,000.

Analyst Ratings Changes

A number of research analysts recently issued reports on AGL shares. Royal Bank of Canada lifted their price objective on shares of agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Needham & Company LLC reiterated a "hold" rating on shares of agilon health in a research report on Friday, March 21st. Robert W. Baird dropped their target price on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a report on Tuesday, April 15th. Cowen reaffirmed a "hold" rating on shares of agilon health in a report on Tuesday, April 15th. Finally, Sanford C. Bernstein raised shares of agilon health from a "market perform" rating to an "outperform" rating and increased their price objective for the company from $3.30 to $8.50 in a research note on Tuesday, April 8th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, agilon health currently has an average rating of "Hold" and a consensus target price of $4.81.

Read Our Latest Report on AGL

agilon health Stock Up 5.9 %

Shares of AGL stock traded up $0.23 on Friday, hitting $4.16. The stock had a trading volume of 4,728,140 shares, compared to its average volume of 4,858,557. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $7.73. The business has a 50 day moving average of $4.23 and a 200 day moving average of $3.17. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The stock has a market cap of $1.72 billion, a price-to-earnings ratio of -4.43 and a beta of 0.38.

agilon health Company Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines